Maxim raises price target to $23?, page-23

In fact, Regenx bio have raised 18 times more cash in the last year than Benitec was able to at their IPO. It probably helps that gene therapy pioneer James Wilson is involved, they are US based, and they weren't already listed on an exchange leaving it wide open to manipulation by a hedge fund dumping a large amount of stock.

Still, comparing Regenx bio's website to BLTs indicates to me that there will be a very strong reaction to any positive efficacy data.